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Preface from “Guest Editor”Liposomeswere selected as the theme topic of thememorable
first special issue of Asian Journal of Pharmaceutical Sciences.
Before the advent of nanomedicine era, liposomes have been
studied and commercialized for drug delivery systems. As
compared to other emerging nanocarriers, liposomes have
unparalleled high biocompatibility, the record of commer-
cialization, and long history of clinical use. The versatile
loading techniques, the variation of surface charges and lipid
compositions contribute to the longevity of liposomes until
now.
The special issue encompasses the various applications of
liposomes in the perspective of various cargo molecules, tar-
geted delivery, routes of administration, and manufacturing
techniques. Dr. Zhang (Peking University, China) overviewed
the current status of liposomes carrying chemical drugs and
cancer vaccine antigens. Dr. Oh (Seoul National University,
South Korea) discussed the applications of cationic liposomes
for delivery of nucleic acid drugs such as plasmid DNA, and
RNA drugs. In addition to the chemical drugs, vaccines, and
nucleic acid drugs, the natural extracts are another main
avenues of liposomal formulations. Dr. Sarisuta (Mahidol
University, Thailand) suggested that the liposomes of Aspar-
agus racemous extracts were affected by the preparation
methods.
When it comes to the targeted delivery area, Dr. Lee
(Chung-Ang University, South Korea) reviewed the use of
liposomes for intestinal lymphatic delivery. The use of folicPeer review under responsibility of Shenyang Pharmaceutical Univer
Production and hosting by Elsevieracids for the delivery of liposomal vincristine was reported by
Dr. Lu (Fudan University, China). From the industrial
manufacturing perspective, the sterilization techniques of
systemically administered liposomes were reviewed by
Dr. Chiu (National University of Singapore, Singapore).
In addition to the systemic delivery, the applications of li-
posomes for non-systemic delivery routes have been dis-
cussed. Dr. Takeuchi (Gifu University, Japan) reported the
ophthalmic delivery of bromfenac-loaded mucoadhesive li-
posomes. The transdermal application and skin permeability
of ellagic acid-containing liposomes were discussed by Dr.
Junyaprasert (Mahidol University, Thailand).
The special issue emphasizes that “liposomes” are the
carriers of numerous potential applications. Given the active
ongoing researches on liposomes, the list of clinical trials
using liposomes is expected to keep longer in the near future.
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